Your browser doesn't support javascript.
loading
Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial.
Dellapasqua, Silvia; Trillo Aliaga, Pamela; Munzone, Elisabetta; Bagnardi, Vincenzo; Pagan, Eleonora; Montagna, Emilia; Cancello, Giuseppe; Ghisini, Raffaella; Sangalli, Claudia; Negri, Mara; Mazza, Manuelita; Iorfida, Monica; Cardillo, Anna; Sciandivasci, Angela; Bianco, Nadia; De Maio, Ana Paula; Milano, Monica; Campennì, Giuseppe Maria; Sansonno, Loredana; Viale, Giuseppe; Morra, Anna; Leonardi, Maria Cristina; Galimberti, Viviana; Veronesi, Paolo; Colleoni, Marco.
Afiliação
  • Dellapasqua S; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Trillo Aliaga P; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Munzone E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, 20126 Milan, Italy.
  • Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, 20126 Milan, Italy.
  • Montagna E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Cancello G; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Ghisini R; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Sangalli C; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Negri M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Mazza M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Iorfida M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Cardillo A; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Sciandivasci A; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Bianco N; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • De Maio AP; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Milano M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Campennì GM; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Sansonno L; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Viale G; Department of Pathology, European Institute of Oncology IRCCS and University of Milan, 20141 Milan, Italy.
  • Morra A; Division of Radiotherapy, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Leonardi MC; Division of Radiotherapy, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Galimberti V; Division of Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Veronesi P; Division of Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Curr Oncol ; 28(6): 5167-5178, 2021 12 07.
Article em En | MEDLINE | ID: mdl-34940072

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article